ProfileGDS5822 / ILMN_2864695
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 60% 24% 37% 23% 6% 9% 37% 23% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 128.460
GSM1276600PDAC Late Ablation Control 215.824
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 115.237
GSM1276603PDAC Late Ablation 212.923
GSM1276604PDAC Late Ablation 36.46
GSM1303940PDAC Late Ablation_anti-CTLA4 19.29
GSM1303941PDAC Late Ablation_anti-CTLA4 217.637
GSM1303942PDAC Late Ablation_anti-CTLA4 311.723